Homology Medicines, Inc.
Bedford, US · Founded 2015 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
SG
Steven GillisDirector
SR
Siyamak RastyExecutive Officer
RG
Richard GregoryDirector
KP
Kush ParmarDirector
AS
Albert SeymourExecutive Officer
AT
Arthur TzianabosExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$83.5MraisedAug 2017 · 19 investors · PharmaceuticalsRule 506(b)
▶$83.5MraisedAug 2017 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kush ParmarDirector
- Brad SmithExecutive Officer
- Richard GregoryDirector
- Mahendra ShahDirector
- Cameron WheelerDirector
- Arthur TzianabosExecutive Officer, Director
- Siyamak RastyExecutive Officer
- Albert SeymourExecutive Officer
- Steven GillisDirector
- Offering amount
- $83.5M
- Amount sold
- $83.5M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$43.6MraisedFeb 2017 · 7 investors · PharmaceuticalsRule 506(b)
▶$43.6MraisedFeb 2017 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven GillisDirector
- Arthur TzianabosExecutive Officer, Director
- Siyamak RastyExecutive Officer
- Richard GregoryDirector
- Kush ParmarDirector
- Albert SeymourExecutive Officer
- Offering amount
- $43.6M
- Amount sold
- $43.6M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.